Publication:
Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment

dc.contributor.authorTina Kaussen_US
dc.contributor.authorKaren Gaudinen_US
dc.contributor.authorAlexandra Gauberten_US
dc.contributor.authorBoubakar Baen_US
dc.contributor.authorSerena Tagliaferrien_US
dc.contributor.authorFawaz Fawazen_US
dc.contributor.authorJean Louis Fabreen_US
dc.contributor.authorJean Michel Boironen_US
dc.contributor.authorXavier Lafargeen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.authorPiero L. Olliaroen_US
dc.contributor.authorPascal Milleten_US
dc.contributor.otherDeveloppements Analytiques et Pharmaceutiques Appliques aux Maladies Negligees et Aux Contrefaconsen_US
dc.contributor.otherAccelera S.r.l.en_US
dc.contributor.otherOTECI (Office Technique d'Etude et de Coopération Internationale)en_US
dc.contributor.otherEtablissement Francais du Sangen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherNuffield Department of Clinical Medicineen_US
dc.contributor.otherOrganisation Mondiale de la Santeen_US
dc.date.accessioned2018-06-11T05:22:49Z
dc.date.available2018-06-11T05:22:49Z
dc.date.issued2012-10-15en_US
dc.description.abstractThe aim of this study was to identify a candidate formulation for further development of a home or near-home administrable paediatric rectal form of a broad-spectrum antibiotic - specially intended for (emergency) use in tropical rural settings, in particular for children who cannot take medications orally and far from health facilities where injectable treatments can be given. Azithromycin, a broad-spectrum macrolide used orally or intravenously for the treatment of respiratory tract, skin and soft tissue infections, was selected because of its pharmacokinetic and therapeutic properties. Azithromycin in vitro solubility and stability in physiologically relevant conditions were studied. Various pharmaceutical forms, i.e. rectal suspension, two different rectal gels, polyethylene glycol (PEG) suppository and hard gelatin capsule (HGC) were assessed for in vitro dissolution and in vivo bioavailability in the rabbit. Azithromycin PEG suppository appears to be a promising candidate. © 2012 Elsevier B.V. All rights reserved.en_US
dc.identifier.citationInternational Journal of Pharmaceutics. Vol.436, No.1-2 (2012), 624-630en_US
dc.identifier.doi10.1016/j.ijpharm.2012.07.030en_US
dc.identifier.issn18733476en_US
dc.identifier.issn03785173en_US
dc.identifier.other2-s2.0-84865287290en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/15155
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84865287290&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleScreening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatmenten_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84865287290&origin=inwarden_US

Files

Collections